Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical/BS
Sun Pharma Announces Acquisition of Remaining Stake in Taro Pharmaceutical
India’s Sun Pharmaceutical Industries Ltd has revealed plans to acquire the remaining outstanding shares of Taro Pharmaceutical Industries Ltd. Valued at approximately 2,891 crore Indian Rupees, this strategic move is expected to strengthen Sun Pharma’s global position.
The acquisition, subject to regulatory approvals, is anticipated to enhance operational efficiency and contribute to long-term growth.
The deal is set to close in the first half of 2024, leading to Taro becoming a privately held company.
About the Author
VoM News Desk -is an online web portal in jammu Kashmir offers regional, National & global news.
Latest Posts
- COWSAR Brand Launches BL990 Countertop Blender, Bringing Powerful, Sub-Minute Blending to Everyday Drink Preparation25 Oct 2026
- 17 Arrested in Joint Security Operation at Kuki Insurgent Camp in Manipur25 Oct 2026
- Uttar Pradesh CEO Issues Notices to Five Azamgarh Election Officials Over Duplicate Voter Entries25 Oct 2026
- Enforcement Directorate Moves Supreme Court Against Quashing of Money Laundering Case Against NewsClick25 Oct 2026
- India Issues Fresh Advisory for Umrah Pilgrims Stranded in Saudi Arabia Amid Flight Disruptions25 Oct 2026
- Centre Extends Defence Secretary Rajesh Kumar Singh’s Tenure Till October 202725 Oct 2026
- Iran Accuses Germany of Shifting Position on US-Israeli Military Actions; Foreign Ministry spokesperson Esmaeil Baghaei Issues Remark25 Oct 2026
- Former US President Barack Obama Criticises Trump’s Iran War, Blames Conflict for Rising Prices Across US25 Oct 2026
- Iran Halts LPG Supplies to Pakistan Amid Border Closure, Cooking Gas Prices Surge 56%24 Oct 2026
- Chinese-Russian Medical Team Reportedly Performs First Spinal Cord Transplant in Moscow24 Oct 2026